Title: ASSEMBLY BILL NO. 378–ASSEMBLYMEMBERS CARTER, GRAY,
Official Title: ASSEMBLY BILL NO. 378–ASSEMBLYMEMBERS CARTER, GRAY,
Number of Sections: 1
Source: versions - As Introduced
Media Type: application/pdf
Strikethrough Detection: 10 sections found

================================================================================

Section 1:
A.B. 378
D’SILVA, HANSEN, BROWN-MAY; ANDERSON, CONSIDINE,
DALIA, DICKMAN, EDGEWORTH, GONZÁLEZ, HIBBETTS,
HUNT, JACKSON, KARRIS, MOSCA, NGUYEN,
ORENTLICHER, ROTH AND WATTS
MARCH 10, 2025
____________
JOINT SPONSORS: SENATORS HANSEN, NGUYEN,
STONE; AND OHRENSCHALL
____________
Referred to Committee on Health and Human Services
SUMMARY—Creates the Alternative Therapy Pilot Program.
(BDR 40-820)
FISCAL NOTE: Effect on Local Government: No.
Effect on the State: Yes.
~
EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted.
AN ACT relating to controlled substances; creating the Alternative
Therapy Pilot Program; requiring the Division of Public
and Behavioral Health of the Department of Health and
Human Services to administer and adopt certain
regulations governing the Program; authorizing the
Division to take certain actions with respect to the
Program; requiring the Division to authorize at least one
person to cultivate, manufacture or produce psychedelic
substances for use in the Program; requiring the Division
to submit to the Legislature an annual report concerning
the Program; providing immunity from civil, criminal and
administrative liability to a participant in the Program for
certain conduct relating to the Program; and providing
other matters properly relating thereto.
Legislative Counsel’s Digest:
1 Section 9 of this bill creates the Alternative Therapy Pilot Program for the
2 purpose of providing certain patients who have been diagnosed with a mental
3 health condition access to treatment involving the administration, under medical
-
*AB378*
– 2 –
4 supervision and control, of psychedelic substances through the development and
5 implementation of experimental and investigational pilot clinic programs. Section 9
6 requires the Division of Public and Behavioral Health of the Department of Health
7 and Human Services to administer the Program and, within the limits of available
8 funds, develop and implement experimental and investigational pilot programs for
9 the provision of alternative therapies. Section 7 of this bill defines “psychedelic
10 substance” to mean psilocybin, psilocin, dimethyltryptamine, ibogaine or
11 mescaline.
12 Section 10 of this bill requires the Division to adopt regulations to carry out the
13 provisions governing the Program. Section 11 of this bill authorizes the Division to
14 carry out or contract for certain programs for research and education. Section 12 of
15 this bill requires the Division to authorize at least one person to cultivate,
16 manufacture or otherwise produce psychedelic substances for use in the Program.
17 Section 12 requires such a person to comply with certain requirements.
18 Section 13 of this bill requires the Division to collect comprehensive data
19 concerning all alternative therapies provided under any pilot clinic program
20 developed and implemented under the Program. Sections 13 and 17 of this bill
21 require any data collected that would lead to the identification of any patient
22 participating in a pilot clinic program developed and implemented under the
23 Program to be kept confidential and securely maintained. Section 13 also requires
24 the Division to submit an annual report concerning the Program to the Legislature.
25 Section 15 of this bill authorizes the Division to coordinate with other state
26 agencies for certain purposes relating to the Program. Section 15 also requires the
27 Division to take all actions which are feasible to ensure that all pilot clinic
28 programs developed and implemented under the Program comply with all
29 applicable federal requirements or guidelines relating to the clinical or experimental
30 use of controlled substances.
31 Existing law requires the State Board of Pharmacy to administer the Uniform
32 Controlled Substances Act and to add substances to or delete or reschedule all
33 substances enumerated in schedules I, II, III, IV and V by regulation. (NRS
34 453.146) Existing regulations list psilocybin, psilocin, dimethyltryptamine,
35 ibogaine and mescaline as schedule I controlled substances. (NAC 453.510)
36 Existing law prohibits certain acts relating to controlled substances, including,
37 without limitation: (1) importing, transporting, selling, exchanging, bartering,
38 supplying, prescribing, dispensing, giving away or administering the controlled
39 substance; (2) manufacturing or compounding the controlled substance; (3)
40 unlawfully possessing the controlled substance; and (4) trafficking in the controlled
41 substance. (NRS 453.321, 453.322, 453.336, 453.337, 453.338, 453.3385) Section
42 14 of this bill provides that any person who has been approved by the Division to
43 participate in a pilot clinic program developed and implemented under the Program
44 who engages in certain conduct involving a psychedelic substance within the scope
45 of the participation of the person in the Program is immune from civil, criminal and
46 administrative liability arising from that conduct and any such conduct must not
47 constitute the basis for any investigation, detention, search, seizure, arrest,
48 prosecution or other legal penalty against the person.
49 Section 16 of this bill authorizes the Division to accept certain sources of
50 money and enter into certain contracts and agreements to carry out the Program.
51 Sections 2-7 of this bill add necessary definitions of terms. Section 8 of this
52 bill sets forth certain legislative findings and declarations.
-
*AB378*
– 3 –
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS:
1 Section 1. Chapter 453 of NRS is hereby amended by adding
2 thereto the provisions set forth as sections 2 to 16, inclusive, of this
3 act.
4 Sec. 2. As used in sections 2 to 16, inclusive, of this act,
5 unless the context otherwise requires, the words and terms defined
6 in sections 3 to 7, inclusive, of this act have the meanings ascribed
7 to them in those sections.
8 Sec. 3. “Alternative therapy” means any treatment of a
9 patient for a mental health condition that involves administering
10 to the patient, under medical supervision and control, a
11 psychedelic substance.
12 Sec. 4. “Division” means the Division of Public and
13 Behavioral Health of the Department.
14 Sec. 5. “Medical facility” has the meaning ascribed to it in
15 NRS 449.0151.
16 Sec. 6. “Program” means the Alternative Therapy Pilot
17 Program created by section 9 of this act.
18 Sec. 7. “Psychedelic substance” means any of the following
19 substances:
20 1. Psilocybin.
21 2. Psilocin.
22 3. Dimethyltryptamine.
23 4. Ibogaine.
24 5. Mescaline.
25 Sec. 8. The Legislature hereby finds and declares that:
26 1. Mental health conditions, including, without limitation,
27 post-traumatic stress disorder, depression and anxiety disorders
28 require innovative approaches to treatment.
29 2. It is the policy of this State to encourage and promote
30 programs which provide for the treatment and rehabilitation of
31 persons with a mental health condition through alternative
32 treatments that may include, without limitation, the administration
33 of controlled substances in a clinical setting.
34 3. Providing access to treatments that involve the
35 administration of psychedelic substances, under proper medical
36 supervision, may contribute to the public welfare by fostering
37 enhanced treatment outcomes.
38 Sec. 9. 1. The Alternative Therapy Pilot Program is hereby
39 created for the purpose of providing certain patients who have
40 been diagnosed with a mental health condition access to treatment
41 involving the administration, under medical supervision and
42 control, of psychedelic substances through the development and
-
*AB378*
– 4 –
1 implementation of experimental and investigational pilot clinic
2 programs. The Division shall administer the Program.
3 2. As part of the Program, the Division shall, within the limits
4 of available funds, including, without limitation, legislative
5 appropriations, develop and implement experimental and
6 investigational pilot clinic programs for the provision of
7 alternative therapies. All alternative therapies provided under such
8 a pilot clinic program must be provided:
9 (a) By or under the supervision of a practitioner who has been
10 approved by the Division;
11 (b) At a medical facility or other location that has been
12 approved by the Division;
13 (c) To a patient who has been approved by the Division and
14 who meets all of the following criteria:
15 (1) The patient has been diagnosed with a mental health
16 condition;
17 (2) The patient is 21 years of age or older; and
18 (3) The patient has either:
19 (I) Been honorably discharged from the Armed Forces
20 of the United States; or
21 (II) Previously been employed as a first responder, as
22 defined in NRS 193.1678.
23 (d) In compliance with all applicable medical and ethical
24 standards; and
25 (e) In conjunction with any supporting or rehabilitative
26 services necessary to enhance the efficacy of treatment with
27 psychedelic substances.
28 3. In administering the Program, the Division shall:
29 (a) Ensure that all alternative therapies provided under a pilot
30 clinic program pursuant to subsection 2 are provided in
31 accordance with the requirements set forth in that subsection.
32 (b) Approve qualified practitioners, patients and medical
33 facilities or other locations to participate in a pilot clinic program
34 pursuant to subsection 2.
35 (c) Ensure that comprehensive data concerning all aspects of
36 alternative therapies provided under a pilot clinic program
37 pursuant to subsection 2 is collected and reported to the Division.
38 Such data must include, data concerning longitudinal outcomes
39 for participants in such a program.
40 (d) Provide for the participation in the Program of institutions
41 of higher education in this State, which may include, without
42 limitation, the training of practitioners, research on alternative
43 therapies and the evaluation of therapeutic protocols.
-
*AB378*
– 5 –
1 Sec. 10. 1. The Division shall adopt regulations to carry
2 out the provisions of sections 2 to 16, inclusive, of this act. The
3 regulations must include, without limitation:
4 (a) Procedures and criteria for determining whether to
5 approve a practitioner, patient, medical facility or other location to
6 participate in a pilot clinic program developed and implemented
7 under the Program;
8 (b) Protocols to ensure that psychedelic substances are
9 handled, stored and administered safely, ethically and in a manner
10 consistent with federal and state law;
11 (c) Standards for the reporting of the outcomes and
12 effectiveness of any alternative therapies provided through a pilot
13 clinic program developed and implemented under the Program;
14 (d) Any provisions the Division determines to be necessary to
15 ensure that pilot clinic programs developed and implemented
16 under the Program receive appropriate medical supervision; and
17 (e) Any provisions the Division determines to be necessary to
18 protect the public health and safety.
19 2. The regulations adopted pursuant to subsection 1 must be
20 designed to:
21 (a) Ensure that the provision of any alternative therapy under
22 a pilot clinic program developed and implemented under the
23 Program conforms to the highest standards of patient safety,
24 medical ethics and informed consent; and
25 (b) Promote the health and welfare of persons with a mental
26 health condition, consistent with the declared policy of this State.
27 Sec. 11. In developing and implementing pilot clinic
28 programs under the Program, the Division may carry out or
29 contract for any programs of research and education that the
30 Division deems necessary to:
31 1. Develop new approaches for the treatment of mental health
32 conditions through the administration of psychedelic substances;
33 2. Improve the quality or availability of prevention and
34 treatment services; and
35 3. Train practitioners and other personnel who require
36 specialized instruction to safely provide alternative therapies
37 under a pilot clinic program.
38 Sec. 12. 1. The Division shall authorize at least one person
39 to cultivate, manufacture or otherwise produce psychedelic
40 substances for use in any pilot clinic program developed and
41 implemented under the Program.
42 2. A person authorized to cultivate, manufacture or otherwise
43 produce psychedelic substances pursuant to subsection 1 shall:
-
*AB378*
– 6 –
1 (a) Comply with all standards and requirements, including,
2 without limitation, security requirements and reporting
3 requirements, established by the Division;
4 (b) Obtain and maintain any registration required by this
5 chapter and the regulations adopted pursuant thereto to engage in
6 the production, distribution or use of controlled substances for the
7 purpose of conducting research; and
8 (c) Not cultivate, manufacture or otherwise produce or
9 distribute any psychedelic substance except as authorized by the
10 Division in connection with the Program.
11 Sec. 13. 1. The Division shall collect comprehensive data
12 concerning all alternative therapies provided under any pilot clinic
13 program developed and implemented under the Program. Such
14 data must include, without limitation, the following data
15 concerning each patient who participates in such a pilot clinic
16 program:
17 (a) Demographic information.
18 (b) A baseline mental health assessment.
19 (c) Outcome measures, including, without limitation,
20 longitudinal data after treatments have concluded.
21 (d) Any data relating to monitoring performed for ethical or
22 safety purposes.
23 2. Any data collected pursuant to subsection 1 that would
24 lead to the identification of any patient participating in a pilot
25 clinic program developed and implemented under the Program is
26 confidential and must be securely maintained by each person who
27 has possession, custody or control of the data.
28 3. On or before January 1 of each year the Division shall
29 submit to the Director of the Legislative Counsel Bureau for
30 transmittal to the Legislature a report on the status and results of
31 the Program. The report must not contain any information that
32 would lead to the identification of any patient participating in a
33 pilot clinic program developed and implemented under the
34 Program.
35 Sec. 14. Notwithstanding any other provision of law, any
36 person who has been approved by the Division to participate in a
37 pilot clinic program developed and implemented under the
38 Program, to produce psychedelic substances for use in such pilot
39 clinic programs or to otherwise participate in the Program and
40 who engages in any conduct relating to psychedelic substances
41 within the scope of his or her participation in the Program and in
42 compliance with the provisions of sections 2 to 16, inclusive, of
43 this act and any regulations adopted pursuant thereto is immune
44 from civil, criminal and administrative liability arising from that
45 conduct and any such conduct may not constitute the basis for any
-
*AB378*
– 7 –
1 investigation, detention, search, seizure, arrest, prosecution or
2 other legal penalty against the person.
3 Sec. 15. 1. The Division may coordinate with other state
4 agencies, including, without limitation, the Board and other
5 health care licensing boards, as defined in NRS 629.079, to
6 facilitate the oversight of pilot clinic programs developed and
7 implemented under the Program.
8 2. To the extent consistent with federal law, the Division shall
9 take all actions which are feasible to ensure that all pilot clinic
10 programs developed and implemented under the Program comply
11 with all applicable federal requirements or guidelines relating to
12 the clinical or experimental use of controlled substances.
13 Sec. 16. 1. The Division may accept gifts, grants, donations
14 or other sources of money to carry out the provisions of sections 2
15 to 16, inclusive, of this act, including, without limitation, to
16 support or expand pilot clinic programs developed and
17 implemented under the Program.
18 2. The Division may enter into contracts and other lawful
19 agreements with private or public entities to assist the Division in
20 carrying out the provisions of sections 2 to 16, inclusive, of this
21 act, including, without limitation, contracts or agreements for the
22 purpose of developing, implementing or evaluating pilot clinic
23 programs under the Program or for the production or distribution
24 of psychedelic substances for use in such pilot clinic programs.
25 Sec. 17. NRS 239.010 is hereby amended to read as follows:
26 239.010 1. Except as otherwise provided in this section and
27 NRS 1.4683, 1.4687, 1A.110, 3.2203, 41.0397, 41.071, 49.095,
28 49.293, 62D.420, 62D.440, 62E.516, 62E.620, 62H.025, 62H.030,
29 62H.170, 62H.220, 62H.320, 75A.100, 75A.150, 76.160, 78.152,
30 80.113, 81.850, 82.183, 86.246, 86.54615, 87.515, 87.5413,
31 87A.200, 87A.580, 87A.640, 88.3355, 88.5927, 88.6067, 88A.345,
32 88A.7345, 89.045, 89.251, 90.730, 91.160, 116.757, 116A.270,
33 116B.880, 118B.026, 119.260, 119.265, 119.267, 119.280,
34 119A.280, 119A.653, 119A.677, 119B.370, 119B.382, 120A.640,
35 120A.690, 125.130, 125B.140, 126.141, 126.161, 126.163, 126.730,
36 127.007, 127.057, 127.130, 127.140, 127.2817, 128.090, 130.312,
37 130.712, 136.050, 159.044, 159A.044, 164.041, 172.075, 172.245,
38 176.01334, 176.01385, 176.015, 176.0625, 176.09129, 176.156,
39 176A.630, 178.39801, 178.4715, 178.5691, 178.5717, 179.495,
40 179A.070, 179A.165, 179D.160, 180.600, 200.3771, 200.3772,
41 200.5095, 200.604, 202.3662, 205.4651, 209.392, 209.3923,
42 209.3925, 209.419, 209.429, 209.521, 211A.140, 213.010, 213.040,
43 213.095, 213.131, 217.105, 217.110, 217.464, 217.475, 218A.350,
44 218E.625, 218F.150, 218G.130, 218G.240, 218G.350, 218G.615,
45 224.240, 226.462, 226.796, 228.270, 228.450, 228.495, 228.570,
-
*AB378*
– 8 –
1 231.069, 231.1285, 231.1473, 232.1369, 233.190, 237.300,
2 239.0105, 239.0113, 239.014, 239B.026, 239B.030, 239B.040,
3 239B.050, 239C.140, 239C.210, 239C.230, 239C.250, 239C.270,
4 239C.420, 240.007, 241.020, 241.030, 241.039, 242.105, 244.264,
5 244.335, 247.540, 247.545, 247.550, 247.560, 250.087, 250.130,
6 250.140, 250.145, 250.150, 268.095, 268.0978, 268.490, 268.910,
7 269.174, 271A.105, 281.195, 281.805, 281A.350, 281A.680,
8 281A.685, 281A.750, 281A.755, 281A.780, 284.4068, 284.4086,
9 286.110, 286.118, 287.0438, 289.025, 289.080, 289.387, 289.830,
10 293.4855, 293.5002, 293.503, 293.504, 293.558, 293.5757, 293.870,
11 293.906, 293.908, 293.909, 293.910, 293B.135, 293D.510, 331.110,
12 332.061, 332.351, 333.333, 333.335, 338.070, 338.1379, 338.1593,
13 338.1725, 338.1727, 348.420, 349.597, 349.775, 353.205,
14 353A.049, 353A.085, 353A.100, 353C.240, 353D.250, 360.240,
15 360.247, 360.255, 360.755, 361.044, 361.2242, 361.610, 365.138,
16 366.160, 368A.180, 370.257, 370.327, 372A.080, 378.290, 378.300,
17 379.0075, 379.008, 379.1495, 385A.830, 385B.100, 387.626,
18 387.631, 388.1455, 388.259, 388.501, 388.503, 388.513, 388.750,
19 388A.247, 388A.249, 391.033, 391.035, 391.0365, 391.120,
20 391.925, 392.029, 392.147, 392.264, 392.271, 392.315, 392.317,
21 392.325, 392.327, 392.335, 392.850, 393.045, 394.167, 394.16975,
22 394.1698, 394.447, 394.460, 394.465, 396.1415, 396.1425, 396.143,
23 396.159, 396.3295, 396.405, 396.525, 396.535, 396.9685,
24 398A.115, 408.3885, 408.3886, 408.3888, 408.5484, 412.153,
25 414.280, 416.070, 422.2749, 422.305, 422A.342, 422A.350,
26 425.400, 427A.1236, 427A.872, 427A.940, 432.028, 432.205,
27 432B.175, 432B.280, 432B.290, 432B.4018, 432B.407, 432B.430,
28 432B.560, 432B.5902, 432C.140, 432C.150, 433.534, 433A.360,
29 439.4941, 439.4988, 439.5282, 439.840, 439.914, 439A.116,
30 439A.124, 439B.420, 439B.754, 439B.760, 439B.845, 440.170,
31 441A.195, 441A.220, 441A.230, 442.330, 442.395, 442.735,
32 442.774, 445A.665, 445B.570, 445B.7773, 449.209, 449.245,
33 449.4315, 449A.112, 450.140, 450B.188, 450B.805, 453.164,
34 453.720, 458.055, 458.280, 459.050, 459.3866, 459.555, 459.7056,
35 459.846, 463.120, 463.15993, 463.240, 463.3403, 463.3407,
36 463.790, 467.1005, 480.535, 480.545, 480.935, 480.940, 481.063,
37 481.091, 481.093, 482.170, 482.368, 482.5536, 483.340, 483.363,
38 483.575, 483.659, 483.800, 484A.469, 484B.830, 484B.833,
39 484E.070, 485.316, 501.344, 503.452, 522.040, 534A.031, 561.285,
40 571.160, 584.655, 587.877, 598.0964, 598.098, 598A.110,
41 598A.420, 599B.090, 603.070, 603A.210, 604A.303, 604A.710,
42 604D.500, 604D.600, 612.265, 616B.012, 616B.015, 616B.315,
43 616B.350, 618.341, 618.425, 622.238, 622.310, 623.131, 623A.137,
44 624.110, 624.265, 624.327, 625.425, 625A.185, 628.418, 628B.230,
45 628B.760, 629.043, 629.047, 629.069, 630.133, 630.2671,
-
*AB378*
– 9 –
1 630.2672, 630.2673, 630.2687, 630.30665, 630.336, 630A.327,
2 630A.555, 631.332, 631.368, 632.121, 632.125, 632.3415,
3 632.3423, 632.405, 633.283, 633.301, 633.427, 633.4715, 633.4716,
4 633.4717, 633.524, 634.055, 634.1303, 634.214, 634A.169,
5 634A.185, 634B.730, 635.111, 635.158, 636.262, 636.342, 637.085,
6 637.145, 637B.192, 637B.288, 638.087, 638.089, 639.183,
7 639.2485, 639.570, 640.075, 640.152, 640A.185, 640A.220,
8 640B.405, 640B.730, 640C.580, 640C.600, 640C.620, 640C.745,
9 640C.760, 640D.135, 640D.190, 640E.225, 640E.340, 641.090,
10 641.221, 641.2215, 641A.191, 641A.217, 641A.262, 641B.170,
11 641B.281, 641B.282, 641C.455, 641C.760, 641D.260, 641D.320,
12 642.524, 643.189, 644A.870, 645.180, 645.625, 645A.050,
13 645A.082, 645B.060, 645B.092, 645C.220, 645C.225, 645D.130,
14 645D.135, 645G.510, 645H.320, 645H.330, 647.0945, 647.0947,
15 648.033, 648.197, 649.065, 649.067, 652.126, 652.228, 653.900,
16 654.110, 656.105, 657A.510, 661.115, 665.130, 665.133, 669.275,
17 669.285, 669A.310, 670B.680, 671.365, 671.415, 673.450, 673.480,
18 675.380, 676A.340, 676A.370, 677.243, 678A.470, 678C.710,
19 678C.800, 679B.122, 679B.124, 679B.152, 679B.159, 679B.190,
20 679B.285, 679B.690, 680A.270, 681A.440, 681B.260, 681B.410,
21 681B.540, 683A.0873, 685A.077, 686A.289, 686B.170, 686C.306,
22 687A.060, 687A.115, 687B.404, 687C.010, 688C.230, 688C.480,
23 688C.490, 689A.696, 692A.117, 692C.190, 692C.3507, 692C.3536,
24 692C.3538, 692C.354, 692C.420, 693A.480, 693A.615, 696B.550,
25 696C.120, 703.196, 704B.325, 706.1725, 706A.230, 710.159,
26 711.600, and section 13 of this act, sections 35, 38 and 41 of
27 chapter 478, Statutes of Nevada 2011 and section 2 of chapter 391,
28 Statutes of Nevada 2013 and unless otherwise declared by law to be
29 confidential, all public books and public records of a governmental
30 entity must be open at all times during office hours to inspection by
31 any person, and may be fully copied or an abstract or memorandum
32 may be prepared from those public books and public records. Any
33 such copies, abstracts or memoranda may be used to supply the
34 general public with copies, abstracts or memoranda of the records or
35 may be used in any other way to the advantage of the governmental
36 entity or of the general public. This section does not supersede or in
37 any manner affect the federal laws governing copyrights or enlarge,
38 diminish or affect in any other manner the rights of a person in any
39 written book or record which is copyrighted pursuant to federal law.
40 2. A governmental entity may not reject a book or record
41 which is copyrighted solely because it is copyrighted.
42 3. A governmental entity that has legal custody or control of a
43 public book or record shall not deny a request made pursuant to
44 subsection 1 to inspect or copy or receive a copy of a public book or
45 record on the basis that the requested public book or record contains
-
*AB378*
– 10 –
1 information that is confidential if the governmental entity can
2 redact, delete, conceal or separate, including, without limitation,
3 electronically, the confidential information from the information
4 included in the public book or record that is not otherwise
5 confidential.
6 4. If requested, a governmental entity shall provide a copy of a
7 public record in an electronic format by means of an electronic
8 medium. Nothing in this subsection requires a governmental entity
9 to provide a copy of a public record in an electronic format or by
10 means of an electronic medium if:
11 (a) The public record:
12 (1) Was not created or prepared in an electronic format; and
13 (2) Is not available in an electronic format; or
14 (b) Providing the public record in an electronic format or by
15 means of an electronic medium would:
16 (1) Give access to proprietary software; or
17 (2) Require the production of information that is confidential
18 and that cannot be redacted, deleted, concealed or separated from
19 information that is not otherwise confidential.
20 5. An officer, employee or agent of a governmental entity who
21 has legal custody or control of a public record:
22 (a) Shall not refuse to provide a copy of that public record in the
23 medium that is requested because the officer, employee or agent has
24 already prepared or would prefer to provide the copy in a different
25 medium.
26 (b) Except as otherwise provided in NRS 239.030, shall, upon
27 request, prepare the copy of the public record and shall not require
28 the person who has requested the copy to prepare the copy himself
29 or herself.
30 Sec. 18. The provisions of subsection 1 of NRS 218D.380 do
31 not apply to any provision of this act which adds or revises a
32 requirement to submit a report to the Legislature.
33 Sec. 19. 1. This section becomes effective upon passage and
34 approval.
35 2. Sections 1 to 18, inclusive, of this act become effective:
36 (a) Upon passage and approval for the purposes of adopting
37 regulations and performing any other preparatory administrative
38 tasks; and
39 (b) On October 1, 2025, for all other purposes.
H
-
*AB378*
[DELETED: BN.3AC,G I O S AR RYS,H,B-M;A,CA AN RNAY NN OE,D,E,G,HA IN DH OZ IS,J,K,M,NT AN AS OA GN,RWR O A1,2 S:SH,N, PS E AN GN;OE  H t A T P P EE S t a a a c g t P a t t t c a w r t t c r t t P a pS o p c p w h b d w a m]
[DELETED: – t m p p d i oS b r t D t a a l o p t cS 1 o t b r t D t c c d a a t p u a p c p a d c t w l t t i o a p i a p c p d a i u tS t t a a w a f t e t a p c d a i u t P c w aE e i s I I I I a V b r ( E r l p p d a m a s I c s ( 4 l p c a r t c s i l ( i t s e b p d g a o a t c ( m o c t c s ( t b f a i d s s aS 1 o t a t D a c s oS]
[DELETED: –S 1  CS 2  A u i s 2 t 1 i o t aS 3  “ t m a t o a t p u m s a c aS 4  “ m t D o P aS 5  “S 6  “ m t A T PS 7  “1  P2  P3  D4  I5  MS 8  T1  M h c i w l s d d a a d2  I i t p o t S t e a p w p f t t a r o w a m h c t a3  P a t t t i t o p s u p m m c t t p w b fS 9  1  T f t p o p c p w h t a u m s a]
[DELETED: – o e a i p c2  A a f i w l l d a i e a p c p f t p o( B( A a m f o o l t h b( T ( T p h b d w a h ( T ( T  ( B  ( P b e a a f r a( I c w a a m a e( I c w a s o r n t e t e o t w3  I( E p p t s 2 a p i( A q p p a m( E t p u a p c p( P h e i t S w m i w t t o p r o a]
[DELETED: –S 1  1  T D s a r t c( P a c f d w t( P t e t p s a( S f t r o t o a( A t p c p d a i( A2  T( E p c p d a i u t c t t h s o p s( PS 1  I d a i p c u t P t D m c o o f a p o r a e t t1  D2  I t q o a o p a3  T p a o p w r i t s p a tS 1  1  T c m o o p p f u i a p c p d a2  A]
[DELETED: –( C w a s a r i l s r a r( O a m a r r b t( N c m o o p oS 1  1  T D s c c d d a i u t P S m i w l t f d e p w p i s a p c( D( A( O m i w l( A2  A d c p t s 1 t w t t i o a p p i a p3  O o b J 1 o e y t D s t t D o t L C B f c p d a i u tS 1  N a o p o l a c p d a i u t p o t o p i t P e i a c r t p s 2]
[DELETED: – d s s a p oS 1  1  T D m c w o s i w l t B a o c l b a d i N 6 t t o o p c p d a2  TS 1  1  T 1 i o t a i w l t o e p c p d a2  T D m e i c a o l o d i o e p cS 1  N2  1  E 1 1 1 3 4 4 4 6 6 7 7 7 7 8 8 8 8 8 8 8 8 9 9 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2]
[DELETED: – 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 6 6 6 6 6 6 6 6 6 6 6 6 6 6]
[DELETED: – 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 7 7 7 7 7 a s 1 o t a s 3 3 a 4 o c a o m m b u t s t2  A g e m n r a b o r3  A b o r s n d a r m p t]
[DELETED: – t i c i t g e c d c o s i w l t c i f t i i t p b o r t i n o4  I r i a e f b m o a e( T ( W ( I( P t p r i a e f o b ( G ( R5  A( S( ES 1  T a t a p o t a w a o r aS 1  1  T2  S( U p a a f t p o a a p a o p a( O]


================================================================================

Raw Text:
A.B. 378
ASSEMBLY BILL NO. 378–ASSEMBLYMEMBERS CARTER, GRAY,
D’SILVA, HANSEN, BROWN-MAY; ANDERSON, CONSIDINE,
DALIA, DICKMAN, EDGEWORTH, GONZÁLEZ, HIBBETTS,
HUNT, JACKSON, KARRIS, MOSCA, NGUYEN,
ORENTLICHER, ROTH AND WATTS
MARCH 10, 2025
____________
JOINT SPONSORS: SENATORS HANSEN, NGUYEN,
STONE; AND OHRENSCHALL
____________
Referred to Committee on Health and Human Services
SUMMARY—Creates the Alternative Therapy Pilot Program.
(BDR 40-820)
FISCAL NOTE: Effect on Local Government: No.
Effect on the State: Yes.
~
EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted.
AN ACT relating to controlled substances; creating the Alternative
Therapy Pilot Program; requiring the Division of Public
and Behavioral Health of the Department of Health and
Human Services to administer and adopt certain
regulations governing the Program; authorizing the
Division to take certain actions with respect to the
Program; requiring the Division to authorize at least one
person to cultivate, manufacture or produce psychedelic
substances for use in the Program; requiring the Division
to submit to the Legislature an annual report concerning
the Program; providing immunity from civil, criminal and
administrative liability to a participant in the Program for
certain conduct relating to the Program; and providing
other matters properly relating thereto.
Legislative Counsel’s Digest:
1 Section 9 of this bill creates the Alternative Therapy Pilot Program for the
2 purpose of providing certain patients who have been diagnosed with a mental
3 health condition access to treatment involving the administration, under medical
-
*AB378*

– 2 –
4 supervision and control, of psychedelic substances through the development and
5 implementation of experimental and investigational pilot clinic programs. Section 9
6 requires the Division of Public and Behavioral Health of the Department of Health
7 and Human Services to administer the Program and, within the limits of available
8 funds, develop and implement experimental and investigational pilot programs for
9 the provision of alternative therapies. Section 7 of this bill defines “psychedelic
10 substance” to mean psilocybin, psilocin, dimethyltryptamine, ibogaine or
11 mescaline.
12 Section 10 of this bill requires the Division to adopt regulations to carry out the
13 provisions governing the Program. Section 11 of this bill authorizes the Division to
14 carry out or contract for certain programs for research and education. Section 12 of
15 this bill requires the Division to authorize at least one person to cultivate,
16 manufacture or otherwise produce psychedelic substances for use in the Program.
17 Section 12 requires such a person to comply with certain requirements.
18 Section 13 of this bill requires the Division to collect comprehensive data
19 concerning all alternative therapies provided under any pilot clinic program
20 developed and implemented under the Program. Sections 13 and 17 of this bill
21 require any data collected that would lead to the identification of any patient
22 participating in a pilot clinic program developed and implemented under the
23 Program to be kept confidential and securely maintained. Section 13 also requires
24 the Division to submit an annual report concerning the Program to the Legislature.
25 Section 15 of this bill authorizes the Division to coordinate with other state
26 agencies for certain purposes relating to the Program. Section 15 also requires the
27 Division to take all actions which are feasible to ensure that all pilot clinic
28 programs developed and implemented under the Program comply with all
29 applicable federal requirements or guidelines relating to the clinical or experimental
30 use of controlled substances.
31 Existing law requires the State Board of Pharmacy to administer the Uniform
32 Controlled Substances Act and to add substances to or delete or reschedule all
33 substances enumerated in schedules I, II, III, IV and V by regulation. (NRS
34 453.146) Existing regulations list psilocybin, psilocin, dimethyltryptamine,
35 ibogaine and mescaline as schedule I controlled substances. (NAC 453.510)
36 Existing law prohibits certain acts relating to controlled substances, including,
37 without limitation: (1) importing, transporting, selling, exchanging, bartering,
38 supplying, prescribing, dispensing, giving away or administering the controlled
39 substance; (2) manufacturing or compounding the controlled substance; (3)
40 unlawfully possessing the controlled substance; and (4) trafficking in the controlled
41 substance. (NRS 453.321, 453.322, 453.336, 453.337, 453.338, 453.3385) Section
42 14 of this bill provides that any person who has been approved by the Division to
43 participate in a pilot clinic program developed and implemented under the Program
44 who engages in certain conduct involving a psychedelic substance within the scope
45 of the participation of the person in the Program is immune from civil, criminal and
46 administrative liability arising from that conduct and any such conduct must not
47 constitute the basis for any investigation, detention, search, seizure, arrest,
48 prosecution or other legal penalty against the person.
49 Section 16 of this bill authorizes the Division to accept certain sources of
50 money and enter into certain contracts and agreements to carry out the Program.
51 Sections 2-7 of this bill add necessary definitions of terms. Section 8 of this
52 bill sets forth certain legislative findings and declarations.
-
*AB378*

– 3 –
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS:
1 Section 1. Chapter 453 of NRS is hereby amended by adding
2 thereto the provisions set forth as sections 2 to 16, inclusive, of this
3 act.
4 Sec. 2. As used in sections 2 to 16, inclusive, of this act,
5 unless the context otherwise requires, the words and terms defined
6 in sections 3 to 7, inclusive, of this act have the meanings ascribed
7 to them in those sections.
8 Sec. 3. “Alternative therapy” means any treatment of a
9 patient for a mental health condition that involves administering
10 to the patient, under medical supervision and control, a
11 psychedelic substance.
12 Sec. 4. “Division” means the Division of Public and
13 Behavioral Health of the Department.
14 Sec. 5. “Medical facility” has the meaning ascribed to it in
15 NRS 449.0151.
16 Sec. 6. “Program” means the Alternative Therapy Pilot
17 Program created by section 9 of this act.
18 Sec. 7. “Psychedelic substance” means any of the following
19 substances:
20 1. Psilocybin.
21 2. Psilocin.
22 3. Dimethyltryptamine.
23 4. Ibogaine.
24 5. Mescaline.
25 Sec. 8. The Legislature hereby finds and declares that:
26 1. Mental health conditions, including, without limitation,
27 post-traumatic stress disorder, depression and anxiety disorders
28 require innovative approaches to treatment.
29 2. It is the policy of this State to encourage and promote
30 programs which provide for the treatment and rehabilitation of
31 persons with a mental health condition through alternative
32 treatments that may include, without limitation, the administration
33 of controlled substances in a clinical setting.
34 3. Providing access to treatments that involve the
35 administration of psychedelic substances, under proper medical
36 supervision, may contribute to the public welfare by fostering
37 enhanced treatment outcomes.
38 Sec. 9. 1. The Alternative Therapy Pilot Program is hereby
39 created for the purpose of providing certain patients who have
40 been diagnosed with a mental health condition access to treatment
41 involving the administration, under medical supervision and
42 control, of psychedelic substances through the development and
-
*AB378*

– 4 –
1 implementation of experimental and investigational pilot clinic
2 programs. The Division shall administer the Program.
3 2. As part of the Program, the Division shall, within the limits
4 of available funds, including, without limitation, legislative
5 appropriations, develop and implement experimental and
6 investigational pilot clinic programs for the provision of
7 alternative therapies. All alternative therapies provided under such
8 a pilot clinic program must be provided:
9 (a) By or under the supervision of a practitioner who has been
10 approved by the Division;
11 (b) At a medical facility or other location that has been
12 approved by the Division;
13 (c) To a patient who has been approved by the Division and
14 who meets all of the following criteria:
15 (1) The patient has been diagnosed with a mental health
16 condition;
17 (2) The patient is 21 years of age or older; and
18 (3) The patient has either:
19 (I) Been honorably discharged from the Armed Forces
20 of the United States; or
21 (II) Previously been employed as a first responder, as
22 defined in NRS 193.1678.
23 (d) In compliance with all applicable medical and ethical
24 standards; and
25 (e) In conjunction with any supporting or rehabilitative
26 services necessary to enhance the efficacy of treatment with
27 psychedelic substances.
28 3. In administering the Program, the Division shall:
29 (a) Ensure that all alternative therapies provided under a pilot
30 clinic program pursuant to subsection 2 are provided in
31 accordance with the requirements set forth in that subsection.
32 (b) Approve qualified practitioners, patients and medical
33 facilities or other locations to participate in a pilot clinic program
34 pursuant to subsection 2.
35 (c) Ensure that comprehensive data concerning all aspects of
36 alternative therapies provided under a pilot clinic program
37 pursuant to subsection 2 is collected and reported to the Division.
38 Such data must include, data concerning longitudinal outcomes
39 for participants in such a program.
40 (d) Provide for the participation in the Program of institutions
41 of higher education in this State, which may include, without
42 limitation, the training of practitioners, research on alternative
43 therapies and the evaluation of therapeutic protocols.
-
*AB378*

– 5 –
1 Sec. 10. 1. The Division shall adopt regulations to carry
2 out the provisions of sections 2 to 16, inclusive, of this act. The
3 regulations must include, without limitation:
4 (a) Procedures and criteria for determining whether to
5 approve a practitioner, patient, medical facility or other location to
6 participate in a pilot clinic program developed and implemented
7 under the Program;
8 (b) Protocols to ensure that psychedelic substances are
9 handled, stored and administered safely, ethically and in a manner
10 consistent with federal and state law;
11 (c) Standards for the reporting of the outcomes and
12 effectiveness of any alternative therapies provided through a pilot
13 clinic program developed and implemented under the Program;
14 (d) Any provisions the Division determines to be necessary to
15 ensure that pilot clinic programs developed and implemented
16 under the Program receive appropriate medical supervision; and
17 (e) Any provisions the Division determines to be necessary to
18 protect the public health and safety.
19 2. The regulations adopted pursuant to subsection 1 must be
20 designed to:
21 (a) Ensure that the provision of any alternative therapy under
22 a pilot clinic program developed and implemented under the
23 Program conforms to the highest standards of patient safety,
24 medical ethics and informed consent; and
25 (b) Promote the health and welfare of persons with a mental
26 health condition, consistent with the declared policy of this State.
27 Sec. 11. In developing and implementing pilot clinic
28 programs under the Program, the Division may carry out or
29 contract for any programs of research and education that the
30 Division deems necessary to:
31 1. Develop new approaches for the treatment of mental health
32 conditions through the administration of psychedelic substances;
33 2. Improve the quality or availability of prevention and
34 treatment services; and
35 3. Train practitioners and other personnel who require
36 specialized instruction to safely provide alternative therapies
37 under a pilot clinic program.
38 Sec. 12. 1. The Division shall authorize at least one person
39 to cultivate, manufacture or otherwise produce psychedelic
40 substances for use in any pilot clinic program developed and
41 implemented under the Program.
42 2. A person authorized to cultivate, manufacture or otherwise
43 produce psychedelic substances pursuant to subsection 1 shall:
-
*AB378*

– 6 –
1 (a) Comply with all standards and requirements, including,
2 without limitation, security requirements and reporting
3 requirements, established by the Division;
4 (b) Obtain and maintain any registration required by this
5 chapter and the regulations adopted pursuant thereto to engage in
6 the production, distribution or use of controlled substances for the
7 purpose of conducting research; and
8 (c) Not cultivate, manufacture or otherwise produce or
9 distribute any psychedelic substance except as authorized by the
10 Division in connection with the Program.
11 Sec. 13. 1. The Division shall collect comprehensive data
12 concerning all alternative therapies provided under any pilot clinic
13 program developed and implemented under the Program. Such
14 data must include, without limitation, the following data
15 concerning each patient who participates in such a pilot clinic
16 program:
17 (a) Demographic information.
18 (b) A baseline mental health assessment.
19 (c) Outcome measures, including, without limitation,
20 longitudinal data after treatments have concluded.
21 (d) Any data relating to monitoring performed for ethical or
22 safety purposes.
23 2. Any data collected pursuant to subsection 1 that would
24 lead to the identification of any patient participating in a pilot
25 clinic program developed and implemented under the Program is
26 confidential and must be securely maintained by each person who
27 has possession, custody or control of the data.
28 3. On or before January 1 of each year the Division shall
29 submit to the Director of the Legislative Counsel Bureau for
30 transmittal to the Legislature a report on the status and results of
31 the Program. The report must not contain any information that
32 would lead to the identification of any patient participating in a
33 pilot clinic program developed and implemented under the
34 Program.
35 Sec. 14. Notwithstanding any other provision of law, any
36 person who has been approved by the Division to participate in a
37 pilot clinic program developed and implemented under the
38 Program, to produce psychedelic substances for use in such pilot
39 clinic programs or to otherwise participate in the Program and
40 who engages in any conduct relating to psychedelic substances
41 within the scope of his or her participation in the Program and in
42 compliance with the provisions of sections 2 to 16, inclusive, of
43 this act and any regulations adopted pursuant thereto is immune
44 from civil, criminal and administrative liability arising from that
45 conduct and any such conduct may not constitute the basis for any
-
*AB378*

– 7 –
1 investigation, detention, search, seizure, arrest, prosecution or
2 other legal penalty against the person.
3 Sec. 15. 1. The Division may coordinate with other state
4 agencies, including, without limitation, the Board and other
5 health care licensing boards, as defined in NRS 629.079, to
6 facilitate the oversight of pilot clinic programs developed and
7 implemented under the Program.
8 2. To the extent consistent with federal law, the Division shall
9 take all actions which are feasible to ensure that all pilot clinic
10 programs developed and implemented under the Program comply
11 with all applicable federal requirements or guidelines relating to
12 the clinical or experimental use of controlled substances.
13 Sec. 16. 1. The Division may accept gifts, grants, donations
14 or other sources of money to carry out the provisions of sections 2
15 to 16, inclusive, of this act, including, without limitation, to
16 support or expand pilot clinic programs developed and
17 implemented under the Program.
18 2. The Division may enter into contracts and other lawful
19 agreements with private or public entities to assist the Division in
20 carrying out the provisions of sections 2 to 16, inclusive, of this
21 act, including, without limitation, contracts or agreements for the
22 purpose of developing, implementing or evaluating pilot clinic
23 programs under the Program or for the production or distribution
24 of psychedelic substances for use in such pilot clinic programs.
25 Sec. 17. NRS 239.010 is hereby amended to read as follows:
26 239.010 1. Except as otherwise provided in this section and
27 NRS 1.4683, 1.4687, 1A.110, 3.2203, 41.0397, 41.071, 49.095,
28 49.293, 62D.420, 62D.440, 62E.516, 62E.620, 62H.025, 62H.030,
29 62H.170, 62H.220, 62H.320, 75A.100, 75A.150, 76.160, 78.152,
30 80.113, 81.850, 82.183, 86.246, 86.54615, 87.515, 87.5413,
31 87A.200, 87A.580, 87A.640, 88.3355, 88.5927, 88.6067, 88A.345,
32 88A.7345, 89.045, 89.251, 90.730, 91.160, 116.757, 116A.270,
33 116B.880, 118B.026, 119.260, 119.265, 119.267, 119.280,
34 119A.280, 119A.653, 119A.677, 119B.370, 119B.382, 120A.640,
35 120A.690, 125.130, 125B.140, 126.141, 126.161, 126.163, 126.730,
36 127.007, 127.057, 127.130, 127.140, 127.2817, 128.090, 130.312,
37 130.712, 136.050, 159.044, 159A.044, 164.041, 172.075, 172.245,
38 176.01334, 176.01385, 176.015, 176.0625, 176.09129, 176.156,
39 176A.630, 178.39801, 178.4715, 178.5691, 178.5717, 179.495,
40 179A.070, 179A.165, 179D.160, 180.600, 200.3771, 200.3772,
41 200.5095, 200.604, 202.3662, 205.4651, 209.392, 209.3923,
42 209.3925, 209.419, 209.429, 209.521, 211A.140, 213.010, 213.040,
43 213.095, 213.131, 217.105, 217.110, 217.464, 217.475, 218A.350,
44 218E.625, 218F.150, 218G.130, 218G.240, 218G.350, 218G.615,
45 224.240, 226.462, 226.796, 228.270, 228.450, 228.495, 228.570,
-
*AB378*

– 8 –
1 231.069, 231.1285, 231.1473, 232.1369, 233.190, 237.300,
2 239.0105, 239.0113, 239.014, 239B.026, 239B.030, 239B.040,
3 239B.050, 239C.140, 239C.210, 239C.230, 239C.250, 239C.270,
4 239C.420, 240.007, 241.020, 241.030, 241.039, 242.105, 244.264,
5 244.335, 247.540, 247.545, 247.550, 247.560, 250.087, 250.130,
6 250.140, 250.145, 250.150, 268.095, 268.0978, 268.490, 268.910,
7 269.174, 271A.105, 281.195, 281.805, 281A.350, 281A.680,
8 281A.685, 281A.750, 281A.755, 281A.780, 284.4068, 284.4086,
9 286.110, 286.118, 287.0438, 289.025, 289.080, 289.387, 289.830,
10 293.4855, 293.5002, 293.503, 293.504, 293.558, 293.5757, 293.870,
11 293.906, 293.908, 293.909, 293.910, 293B.135, 293D.510, 331.110,
12 332.061, 332.351, 333.333, 333.335, 338.070, 338.1379, 338.1593,
13 338.1725, 338.1727, 348.420, 349.597, 349.775, 353.205,
14 353A.049, 353A.085, 353A.100, 353C.240, 353D.250, 360.240,
15 360.247, 360.255, 360.755, 361.044, 361.2242, 361.610, 365.138,
16 366.160, 368A.180, 370.257, 370.327, 372A.080, 378.290, 378.300,
17 379.0075, 379.008, 379.1495, 385A.830, 385B.100, 387.626,
18 387.631, 388.1455, 388.259, 388.501, 388.503, 388.513, 388.750,
19 388A.247, 388A.249, 391.033, 391.035, 391.0365, 391.120,
20 391.925, 392.029, 392.147, 392.264, 392.271, 392.315, 392.317,
21 392.325, 392.327, 392.335, 392.850, 393.045, 394.167, 394.16975,
22 394.1698, 394.447, 394.460, 394.465, 396.1415, 396.1425, 396.143,
23 396.159, 396.3295, 396.405, 396.525, 396.535, 396.9685,
24 398A.115, 408.3885, 408.3886, 408.3888, 408.5484, 412.153,
25 414.280, 416.070, 422.2749, 422.305, 422A.342, 422A.350,
26 425.400, 427A.1236, 427A.872, 427A.940, 432.028, 432.205,
27 432B.175, 432B.280, 432B.290, 432B.4018, 432B.407, 432B.430,
28 432B.560, 432B.5902, 432C.140, 432C.150, 433.534, 433A.360,
29 439.4941, 439.4988, 439.5282, 439.840, 439.914, 439A.116,
30 439A.124, 439B.420, 439B.754, 439B.760, 439B.845, 440.170,
31 441A.195, 441A.220, 441A.230, 442.330, 442.395, 442.735,
32 442.774, 445A.665, 445B.570, 445B.7773, 449.209, 449.245,
33 449.4315, 449A.112, 450.140, 450B.188, 450B.805, 453.164,
34 453.720, 458.055, 458.280, 459.050, 459.3866, 459.555, 459.7056,
35 459.846, 463.120, 463.15993, 463.240, 463.3403, 463.3407,
36 463.790, 467.1005, 480.535, 480.545, 480.935, 480.940, 481.063,
37 481.091, 481.093, 482.170, 482.368, 482.5536, 483.340, 483.363,
38 483.575, 483.659, 483.800, 484A.469, 484B.830, 484B.833,
39 484E.070, 485.316, 501.344, 503.452, 522.040, 534A.031, 561.285,
40 571.160, 584.655, 587.877, 598.0964, 598.098, 598A.110,
41 598A.420, 599B.090, 603.070, 603A.210, 604A.303, 604A.710,
42 604D.500, 604D.600, 612.265, 616B.012, 616B.015, 616B.315,
43 616B.350, 618.341, 618.425, 622.238, 622.310, 623.131, 623A.137,
44 624.110, 624.265, 624.327, 625.425, 625A.185, 628.418, 628B.230,
45 628B.760, 629.043, 629.047, 629.069, 630.133, 630.2671,
-
*AB378*

– 9 –
1 630.2672, 630.2673, 630.2687, 630.30665, 630.336, 630A.327,
2 630A.555, 631.332, 631.368, 632.121, 632.125, 632.3415,
3 632.3423, 632.405, 633.283, 633.301, 633.427, 633.4715, 633.4716,
4 633.4717, 633.524, 634.055, 634.1303, 634.214, 634A.169,
5 634A.185, 634B.730, 635.111, 635.158, 636.262, 636.342, 637.085,
6 637.145, 637B.192, 637B.288, 638.087, 638.089, 639.183,
7 639.2485, 639.570, 640.075, 640.152, 640A.185, 640A.220,
8 640B.405, 640B.730, 640C.580, 640C.600, 640C.620, 640C.745,
9 640C.760, 640D.135, 640D.190, 640E.225, 640E.340, 641.090,
10 641.221, 641.2215, 641A.191, 641A.217, 641A.262, 641B.170,
11 641B.281, 641B.282, 641C.455, 641C.760, 641D.260, 641D.320,
12 642.524, 643.189, 644A.870, 645.180, 645.625, 645A.050,
13 645A.082, 645B.060, 645B.092, 645C.220, 645C.225, 645D.130,
14 645D.135, 645G.510, 645H.320, 645H.330, 647.0945, 647.0947,
15 648.033, 648.197, 649.065, 649.067, 652.126, 652.228, 653.900,
16 654.110, 656.105, 657A.510, 661.115, 665.130, 665.133, 669.275,
17 669.285, 669A.310, 670B.680, 671.365, 671.415, 673.450, 673.480,
18 675.380, 676A.340, 676A.370, 677.243, 678A.470, 678C.710,
19 678C.800, 679B.122, 679B.124, 679B.152, 679B.159, 679B.190,
20 679B.285, 679B.690, 680A.270, 681A.440, 681B.260, 681B.410,
21 681B.540, 683A.0873, 685A.077, 686A.289, 686B.170, 686C.306,
22 687A.060, 687A.115, 687B.404, 687C.010, 688C.230, 688C.480,
23 688C.490, 689A.696, 692A.117, 692C.190, 692C.3507, 692C.3536,
24 692C.3538, 692C.354, 692C.420, 693A.480, 693A.615, 696B.550,
25 696C.120, 703.196, 704B.325, 706.1725, 706A.230, 710.159,
26 711.600, and section 13 of this act, sections 35, 38 and 41 of
27 chapter 478, Statutes of Nevada 2011 and section 2 of chapter 391,
28 Statutes of Nevada 2013 and unless otherwise declared by law to be
29 confidential, all public books and public records of a governmental
30 entity must be open at all times during office hours to inspection by
31 any person, and may be fully copied or an abstract or memorandum
32 may be prepared from those public books and public records. Any
33 such copies, abstracts or memoranda may be used to supply the
34 general public with copies, abstracts or memoranda of the records or
35 may be used in any other way to the advantage of the governmental
36 entity or of the general public. This section does not supersede or in
37 any manner affect the federal laws governing copyrights or enlarge,
38 diminish or affect in any other manner the rights of a person in any
39 written book or record which is copyrighted pursuant to federal law.
40 2. A governmental entity may not reject a book or record
41 which is copyrighted solely because it is copyrighted.
42 3. A governmental entity that has legal custody or control of a
43 public book or record shall not deny a request made pursuant to
44 subsection 1 to inspect or copy or receive a copy of a public book or
45 record on the basis that the requested public book or record contains
-
*AB378*

– 10 –
1 information that is confidential if the governmental entity can
2 redact, delete, conceal or separate, including, without limitation,
3 electronically, the confidential information from the information
4 included in the public book or record that is not otherwise
5 confidential.
6 4. If requested, a governmental entity shall provide a copy of a
7 public record in an electronic format by means of an electronic
8 medium. Nothing in this subsection requires a governmental entity
9 to provide a copy of a public record in an electronic format or by
10 means of an electronic medium if:
11 (a) The public record:
12 (1) Was not created or prepared in an electronic format; and
13 (2) Is not available in an electronic format; or
14 (b) Providing the public record in an electronic format or by
15 means of an electronic medium would:
16 (1) Give access to proprietary software; or
17 (2) Require the production of information that is confidential
18 and that cannot be redacted, deleted, concealed or separated from
19 information that is not otherwise confidential.
20 5. An officer, employee or agent of a governmental entity who
21 has legal custody or control of a public record:
22 (a) Shall not refuse to provide a copy of that public record in the
23 medium that is requested because the officer, employee or agent has
24 already prepared or would prefer to provide the copy in a different
25 medium.
26 (b) Except as otherwise provided in NRS 239.030, shall, upon
27 request, prepare the copy of the public record and shall not require
28 the person who has requested the copy to prepare the copy himself
29 or herself.
30 Sec. 18. The provisions of subsection 1 of NRS 218D.380 do
31 not apply to any provision of this act which adds or revises a
32 requirement to submit a report to the Legislature.
33 Sec. 19. 1. This section becomes effective upon passage and
34 approval.
35 2. Sections 1 to 18, inclusive, of this act become effective:
36 (a) Upon passage and approval for the purposes of adopting
37 regulations and performing any other preparatory administrative
38 tasks; and
39 (b) On October 1, 2025, for all other purposes.
H
-
*AB378*

[DELETED: BN.3AC,G I O S AR RYS,H,B-M;A,CA AN RNAY NN OE,D,E,G,HA IN DH OZ IS,J,K,M,NT AN AS OA GN,RWR O A1,2 S:SH,N, PS E AN GN;OE  H t A T P P EE S t a a a c g t P a t t t c a w r t t c r t t P a pS o p c p w h b d w a m]
[DELETED: – t m p p d i oS b r t D t a a l o p t cS 1 o t b r t D t c c d a a t p u a p c p a d c t w l t t i o a p i a p c p d a i u tS t t a a w a f t e t a p c d a i u t P c w aE e i s I I I I a V b r ( E r l p p d a m a s I c s ( 4 l p c a r t c s i l ( i t s e b p d g a o a t c ( m o c t c s ( t b f a i d s s aS 1 o t a t D a c s oS]
[DELETED: –S 1  CS 2  A u i s 2 t 1 i o t aS 3  “ t m a t o a t p u m s a c aS 4  “ m t D o P aS 5  “S 6  “ m t A T PS 7  “1  P2  P3  D4  I5  MS 8  T1  M h c i w l s d d a a d2  I i t p o t S t e a p w p f t t a r o w a m h c t a3  P a t t t i t o p s u p m m c t t p w b fS 9  1  T f t p o p c p w h t a u m s a]
[DELETED: – o e a i p c2  A a f i w l l d a i e a p c p f t p o( B( A a m f o o l t h b( T ( T p h b d w a h ( T ( T  ( B  ( P b e a a f r a( I c w a a m a e( I c w a s o r n t e t e o t w3  I( E p p t s 2 a p i( A q p p a m( E t p u a p c p( P h e i t S w m i w t t o p r o a]
[DELETED: –S 1  1  T D s a r t c( P a c f d w t( P t e t p s a( S f t r o t o a( A t p c p d a i( A2  T( E p c p d a i u t c t t h s o p s( PS 1  I d a i p c u t P t D m c o o f a p o r a e t t1  D2  I t q o a o p a3  T p a o p w r i t s p a tS 1  1  T c m o o p p f u i a p c p d a2  A]
[DELETED: –( C w a s a r i l s r a r( O a m a r r b t( N c m o o p oS 1  1  T D s c c d d a i u t P S m i w l t f d e p w p i s a p c( D( A( O m i w l( A2  A d c p t s 1 t w t t i o a p p i a p3  O o b J 1 o e y t D s t t D o t L C B f c p d a i u tS 1  N a o p o l a c p d a i u t p o t o p i t P e i a c r t p s 2]
[DELETED: – d s s a p oS 1  1  T D m c w o s i w l t B a o c l b a d i N 6 t t o o p c p d a2  TS 1  1  T 1 i o t a i w l t o e p c p d a2  T D m e i c a o l o d i o e p cS 1  N2  1  E 1 1 1 3 4 4 4 6 6 7 7 7 7 8 8 8 8 8 8 8 8 9 9 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2]
[DELETED: – 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 5 5 5 5 5 5 6 6 6 6 6 6 6 6 6 6 6 6 6 6]
[DELETED: – 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 7 7 7 7 7 a s 1 o t a s 3 3 a 4 o c a o m m b u t s t2  A g e m n r a b o r3  A b o r s n d a r m p t]
[DELETED: – t i c i t g e c d c o s i w l t c i f t i i t p b o r t i n o4  I r i a e f b m o a e( T ( W ( I( P t p r i a e f o b ( G ( R5  A( S( ES 1  T a t a p o t a w a o r aS 1  1  T2  S( U p a a f t p o a a p a o p a( O]